Akadeum develops the Alerion™ Microbubble Cell Separation System, which utilizes microbubble technology for negative selection and cell depletion workflows to isolate healthier cells from biological samples. This system enhances cell viability and recovery while increasing scalability, addressing the need for more efficient and effective cell therapy manufacturing processes.

Carmine Therapeutics develops non-viral gene therapies using red blood cell extracellular vesicles (RBCEVs) to enhance nucleic acid delivery while minimizing immunogenicity and manufacturing challenges. Their REGENT® platform aims to provide effective treatments for a wide range of diseases by utilizing biocompatible and readily available RBCEVs.

Catio offers an AI‑powered platform that creates a live digital twin of an organization’s tech stack, delivering real‑time architecture visibility and dependency mapping. It provides data‑driven recommendations and automated roadmaps to guide modernization, acquisition integration, and cost‑optimization decisions. The built‑in AI copilot delivers context‑aware answers and continuous guidance, helping engineering teams make informed architecture choices without extensive manual analysis.

Cove is a co‑living platform that offers fully furnished private rooms in curated Singapore properties, with utilities, high‑speed Wi‑Fi, housekeeping and maintenance bundled into a single monthly price. Users can book instantly online for flexible stay lengths—monthly or nightly—and filter listings by location, budget and amenities, while enjoying community events and shared spaces that foster a sense of belonging.

HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.

The startup offers a cybersecurity analytics platform that leverages blockchain technology to detect patterns and vulnerabilities in smart contract code. This platform enables users to identify potential security breaches in real-time, enhancing the integrity of their blockchain applications.

Yumanity Therapeutics develops next-generation immunotherapies that target cancer immune resistance through VISTA blocking mechanisms. The company focuses on addressing diseases caused by protein misfolding, enhancing the efficacy of cancer treatments.

Light is a financial platform that automates general ledger management, accounts receivable, and accounts payable processes for multinational companies using AI-driven analytics and real-time reporting. This solution addresses the complexities of financial operations by streamlining compliance and enhancing efficiency across diverse currencies and regulatory environments.

Provides a shared progress tracking platform for coaches and clients, enabling clients to log actions, track goals, and maintain accountability between sessions. Coaches gain measurable insights into client progress and engagement through customizable logs, reminders, and real-time feedback tools, improving the effectiveness of their practice.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

The startup develops analytic software that enables private market investors to assess the ESG impact and performance of their portfolios by identifying key performance indicators and streamlining data collection. This technology provides actionable insights and performance analysis, allowing investors to make informed operational and investment decisions that enhance financial outcomes.

Lo provides a platform for managing and automating commercial real estate leasing workflows. It centralizes lease documentation, tracks key dates, and streamlines communication between landlords and tenants. This system helps commercial property managers reduce administrative overhead and ensure compliance across their portfolio.

The startup develops biological therapeutics utilizing Chemokine Analogue inhibitors and G-Protein Coupled Receptor modulation to create treatments for serious global health issues. Their focus on enhancing binding affinity and pharmacological control addresses the significant unmet medical needs in therapeutic efficacy.

The startup operates a digital pathology platform that utilizes computational microscopy and artificial intelligence to analyze tissue samples with high speed and accuracy. This technology enables healthcare providers to achieve earlier and more precise diagnoses, ultimately improving patient outcomes and reducing the time required for diagnostic processes.

Peptinovo develops a patented nanoparticle-based drug delivery platform that targets anti-cancer therapies directly to solid tumors, enhancing the efficacy of established chemotherapies while minimizing adverse side effects. Their lead candidate, PNB-281, utilizes a proprietary carrier system to improve treatment outcomes for patients undergoing chemotherapy.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

The startup offers a fully digital UPI credit card that provides guaranteed cashbacks and rewards for every transaction, allowing users to make small payments without minimum spending and convert larger purchases into easy EMIs. This platform addresses the need for a seamless payment solution that combines the convenience of UPI with the benefits of credit card perks, all while ensuring no hidden fees.

Science is a clinical-stage technology company developing biohybrid neural interfaces and advanced neural recording electronics to address serious unmet medical needs in neuroscience. Their technologies aim to enhance neural communication and restore vision, facilitating new treatment possibilities for patients with neurological disorders.

Spinal Simplicity develops minimally invasive spinal fusion devices that preserve native anatomy and facilitate bone healing. Their portfolio includes posterior and lateral implants for lumbar and SI joint fusion, designed to improve surgical outcomes and patient mobility.

The company develops therapeutics that target stroma-intrinsic mechanisms in the tumor microenvironment to combat drug resistance and immune evasion in cancer and autoimmune disorders. By disrupting the supportive role of stroma for cancer cells, their approach enhances understanding of cancer origins and improves patient outcomes.

tem. provides businesses with a platform to purchase 100% renewable energy directly from generators, reducing energy costs by an average of 25% while ensuring full traceability of energy sources. By eliminating intermediary fees, tem. facilitates a more transparent and cost-effective energy transition for companies committed to sustainability.

Xenocor provides single-use, fog-free endoscopes featuring a 1080 HD camera designed for minimally invasive surgical procedures. This technology enhances visualization, reduces cross-contamination risks, and minimizes delays associated with traditional reusable equipment.

Zive is an AI-powered knowledge management platform that organizes and makes company information universally accessible to employees through a single user interface. By automating knowledge retrieval, Zive reduces the average time employees spend searching for information by 35 minutes daily, significantly enhancing productivity.